Literature DB >> 2832473

Structure-function relationships for the IL-2 receptor system. V. Structure-activity analysis of modified and truncated forms of the Tac receptor protein: site-specific mutagenesis of cysteine residues.

C M Rusk1, M P Neeper, L M Kuo, R M Kutny, R J Robb.   

Abstract

IL-2R on activated lymphocytes contain the Tac protein. As part of an effort to characterize this molecule, we examined the structure-activity relationship for each of its 12 Cys residues. A preliminary map of intramolecular disulfide bonding was derived by analysis of cystine-linked enzymatic fragments of the Tac protein. The results indicated that disulfide bonds linked Cys-3 with Cys-147, Cys-131 with Cys-163, and Cys-28,30 with Cys-59,61. The contribution of the Cys residues to an active protein conformation was tested by site-specific mutagenesis, followed by expression of the modified molecules in murine L cells. The results indicated that Cys-192 and -225 could be replaced without affecting ligand binding. In contrast, modification of any of the other 10 Cys residues, either singly or in combinations corresponding to the predicted disulfide bonds, greatly reduced the ability of the corresponding protein to bind IL-2 or either of two mAb (anti-Tac and 7G7/B6) which recognize the Tac protein. Each of the latter mutations also interfered with the molecule's post-translational modification and cell-surface expression. Consistent with these findings, transfection of the L cells with vectors containing truncated Tac cDNA inserts resulted in secretion of Tac fragments capable of ligand binding when the polypeptide chains terminated after Cys-163 (the 10th Cys residue in the full length molecule), but resulted in inactive fragments of Tac which were poorly secreted when they terminated before Cys-163. These findings emphasize the remarkable sensitivity of the active conformation of the Tac molecule to each of the postulated intramolecular disulfide bonds.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2832473

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  8 in total

1.  Serum levels of the low-affinity interleukin-2 receptor molecule (TAC) during IL-2 therapy reflect systemic lymphoid mass activation.

Authors:  S D Voss; J A Hank; C A Nobis; P Fisch; J A Sosman; P M Sondel
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

2.  Structure-function relationships for the interleukin 2 receptor: location of ligand and antibody binding sites on the Tac receptor chain by mutational analysis.

Authors:  R J Robb; C M Rusk; M P Neeper
Journal:  Proc Natl Acad Sci U S A       Date:  1988-08       Impact factor: 11.205

3.  Cysteine mutants of herpes simplex virus type 1 glycoprotein D exhibit temperature-sensitive properties in structure and function.

Authors:  D Long; G H Cohen; M I Muggeridge; R J Eisenberg
Journal:  J Virol       Date:  1990-11       Impact factor: 5.103

4.  Kinetic analysis of ligand binding to interleukin-2 receptor complexes created on an optical biosensor surface.

Authors:  D G Myszka; P R Arulanantham; T Sana; Z Wu; T A Morton; T L Ciardelli
Journal:  Protein Sci       Date:  1996-12       Impact factor: 6.725

5.  Phorbol myristate acetate and calcium ionophore A23187-stimulated human T cells do not express high-affinity IL-2 receptors.

Authors:  R K Chopra; D C Powers; W H Adler; J E Nagel
Journal:  Immunology       Date:  1989-01       Impact factor: 7.397

6.  Limited tryptic digestion of recombinant human interleukin-2: structure-binding relationships with the alpha chain of the interleukin-2 receptor.

Authors:  K Hollfelder; F Rabban; F Wang; Y C Pan
Journal:  J Protein Chem       Date:  1993-08

7.  Mapping of the C3b-binding site of CR1 and construction of a (CR1)2-F(ab')2 chimeric complement inhibitor.

Authors:  K R Kalli; P H Hsu; T J Bartow; J M Ahearn; A K Matsumoto; L B Klickstein; D T Fearon
Journal:  J Exp Med       Date:  1991-12-01       Impact factor: 14.307

8.  Associations between subunit ectodomains promote T cell antigen receptor assembly and protect against degradation in the ER.

Authors:  T Wileman; L P Kane; J Young; G R Carson; C Terhorst
Journal:  J Cell Biol       Date:  1993-07       Impact factor: 10.539

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.